This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Larry O. Gostin, JD; Allan M. Brandt, PhD; Paul D. Cleary, PhD

JAMA. 1991;266(22):3178-3182.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN MARCH 1991, the US Supreme Court agreed to hear the case of Cipollone v Liggett Group,¹ a tobacco liability suit. The Cipollone case gained notoriety in 1988 when it became the first instance in which a jury awarded damages to a plaintiff to compensate harms caused by the use of cigarettes. Since the 1950s, more than 300 such suits had been filed, few had come to trial, and none had been victorious prior to the Cipollone case.^2,3 The Supreme Court will decide whether the federally mandated warning labels on cigarette packages preempt tort actions claiming that manufacturers failed to adequately warn or misled consumers about the health hazards of smoking.

The Court's decision is likely to have profound implications not only for tobacco use and policy in the United States, but for the impact of product liability law on fundamental issues of public health and social policy. . . . [Full Text PDF of this Article]

Author Affiliations
From the American Society of Law and Medicine, Boston, Mass (Mr Gostin), the Department of Social Medicine, University of North Carolina School of Medicine, Chapel Hill (Dr Brandt), and the Department of Health Care Policy, Harvard Medical School, Boston, Mass (Dr Cleary).

Footnotes
Reprint requests to the Office of the Executive Director, American Society of Law and Medicine, 765 Commonwealth Ave, 16th Floor, Boston, MA 02215 (Mr Gostin).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?